Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas

World Journal of Gastroenterology

Volumn 11, Issue 5, 2005, Pages 629-633

  Luo, Bing ^a   Wang, Yun ^a   Wang, Xiao Feng ^a   Liang, Hua ^a   Yan, Li Ping ^a   Huang, Bao Hua ^b   Zhao, Peng ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b YANTAI YUHUANGDING HOSPITAL   (China)

Author keywords

Epstein Barr virus; Gastric carcinomas; Gene expression

Indexed keywords

CELL NUCLEUS ANTIGEN; GENOMIC RNA; LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2; MESSENGER RNA; TUMOR PROMOTER;

ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SOUTHERN BLOTTING; STATISTICAL SIGNIFICANCE; STOMACH CARCINOMA; VIRUS GENOME;

EID: 13544251670     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i5.629     Document Type: Article

References (20)

1. Zur Hausen A, Brink AA, Craanen ME, Middeldorp JM, Meijer CJ, van den Brule AJ. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric carcinomas: expression of the transforming BARF1 gene. Cancer Res 2000; 60: 2745-2748
2. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, Osato T. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 1994; 91: 9131-9135
3. Martel-Renoir D, Grunewald V, Touitou R, Schwaab G, Joab I. Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies. J Gen Virol 1995; 76: 1401-1408
4. Bashir R, Luka J, Cheloha K, Chamberlain M, Hochberg F. Expression of Epstein-Barr virus proteins in primary CNS lymphoma in AIDS patients. Neurology 1993; 43: 2358-2362
5. Ikuta K, Satoh Y, Hoshikawa Y, Sairenji T. Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children. Microbes Infect 2000; 2: 115-120
6. Tokunaga M, Uemura Y, Tokudome T, Ishidate T, Masuda H, Okazaki E, Kaneko K, Naoe S, Ito M, Okamura A. Epstein-Barr virus related gastric cancer in Japan: a molecular pathoepidemiological study. Acta Pathol Jpn 1993; 43: 574-581
7. Hoshikawa Y, Satoh Y, Murakami M, Maeta M, Kaibara N, Ito H, Kurata T, Sairenji T. Evidence of lytic infection of Epstein-Barr virus (EBV) in EBV-positive gastric carcinoma. J Med Virol 2002; 66: 351-359
8. Sugiura M, Imai S, Tokunaga M, Koizumi S, Uchizawa M, Okamoto K, Osato T. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumor cells. Br J Cancer 1996; 74: 625-631
9. Oudejans JJ, van den Brule AJ, Jiwa NM, de Bruin PC, Ossenkoppele GJ, van der Valk P, Walboomers JM, Meijer CJ. BHRF1, the Epstein-Barr virus (EBV) homologue of the bcl-2 proto-oncogene, is transcribed in EBV associated B-cell lymphomas and in reactive lymphocytes. Blood 1995; 86: 1893-1902
10. Kelleher CA, Paterson RK, Dreyfus DH, Streib JE, Xu JW, Takase K, Jones JF, Gelfand EW. Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: Simultaneous early expression of BZLF-1 and its repressor RAZ. Virology 1995; 208: 685-695
11. Prang NS, Hornef MW, Jager M, Wagner HJ, Wolf H, Schwarzmann FM. Lytic replication of Epstein-Barr virus in the peripheral blood: Analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state. Blood 1997; 89: 1665-1677
12. Gulley ML, Pulitzer DR, Eagan PA, Schneider BG. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. Human Pathol 1996; 27: 20-27
13. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-I. Nature 1995; 375: 685-688
14. Miller WE, Earp HS, Raab-Traubn N. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J Virol 1995; 69: 4390-4398
15. Chen F, Hu LF, Ernberg I, Klein G, Winberg G. Coupled transcription of Epstein-Barr virus latent membrane protein (LMP)-1 and LMP-2B genes in nasopharyngeal carcinomas. J Gen Virol 1995; 76 131-138
16. Miller CL, Lee JH, Kieff E, Longnecker R. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc Natl Acad Sci USA 1994; 91: 772-776
17. Lennette ET, Winberg G, Yadav M, Enblad G, Klein G. Antibodies to LMP2A/2B in EBV-carrying malignancies. Eur J Cancer 1995; 31A: 1875-1878
18. Dawson CW, Dawson J, Jones R, Ward K, Young LS. Functional differences between BHRF1, the Epstein-Barr virus-encoded Bcl-2 homologue, and Bcl-2 in human epithelial cells. J Virol 1998; 72: 9016-9024
19. Huang Q, Petros AM, Virgin HW, Fesik SW, Olejniczak ET. Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2. J Mol Biol 2003; 332: 1123-1130
20. Sheng W, Decaussin G, Sumner S, Ooka T. N-terminal domain of BARF1 gene encoded by Epstein-Barr virus is essential for malignant transformation of rodent fibroblasts and activation of BCL-2. Oncogene 2001; 20: 1176-1185